Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (1)
Active Filters (1)
Clear All
145 - 152 of 152 Results
Sort by:
Best Match

Automated characterization of proteins and nucleic acids
Streamline your slab gel electrophoresis, while providing increased throughput and the data formats required for biotherapeutics and genomics workflows.

Characterization of NISTmAb with microfluidic CE-SDS
Application note demonstrating NISTmAb characterization using capillary electrophoresis on the LabChip GXII Touch Protein Characterization System.

An evaluation of control analysis system performance between the LabChip GXII and SCIEX PA800 Plus system
In this app note mAbs were evaluated using the Protein Clear™ HR assay and an orthogonal method, the SCIEX® PA800 Plus system.

Streamline the HEK 293 HCP impurity quantification workflow with new, no-wash AlphaLISA HEK 293 Host Cell Protein Kit
Read our new HEK HCP application note to learn about HEK 293 HCP impurity quantification using AlphaLISA technology (link not available yet)

Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.

A comparative study of two immunoassay platforms to determine lentivirus titer for CAR-T development
This application note demonstrates a comparative quantification of the p24 titer in a lentiviral GFP control sample using Alliance HIV-1 p24 Antigen ELISA and p24 AlphaLISA immunoassay platforms.

Ergonomic high-throughput cell counting plates, 8 x 3 orientation
specification sheet for Ergonomic high-throughput cell counting plates, 8 x 3 orientation

Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases
In this white paper, get details about TPD that offers a novel strategy for neurodegenerative diseases by degrading disease-linked proteins, showing promise in preclinical studies.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.